The 31st Congress of European Pathologists was held September 7 - 11 in Nice, France.

A young scientist Selga Savčenko at the congress presented a report entitled "The value of intestinal metaplasia for the risk stratification of gastric cancer".

The poster emphasized the importance of subtyping of the gastric intestinal metaplasia (IM), which is not currently routine. This is supported by research evidence that up to 30% of high-risk patients may not be identified if IM subtyping is not performed. Because a large proportion of patients with OLGIM I have incomplete IM, which is already a high-risk patient. In contrast, OLGIM I and II are considered low-risk patients and should not be monitored as high-risk.
In addition to the conventional staining method (H&E), AB-PAS and HID are used to identify subtypes of intestinal metaplasia.

Almost 3,900 participants from 92 countries attended the congress.

Share